Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis

Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a sy...

Full description

Saved in:
Bibliographic Details
Published inBMC infectious diseases Vol. 20; no. 1; pp. 1 - 14
Main Authors Qin, Yuanyuan, Huang, Xiaojie, Chen, Hui, Liu, Xinchao, Li, Yao, Hou, Jianhua, Li, Aixin, Yan, Xiaofeng, Chen, Yaokai
Format Journal Article
LanguageEnglish
Published London BioMed Central 29.07.2020
BioMed Central Ltd
BMC
Subjects
Acquired immune deficiency syndrome
AIDS
Analysis
Antifungal agents
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Asymmetry
Bias
Cancer
Care and treatment
CD4 antigen
Diagnostic software
Diagnostic systems
Fungi
Fungicides
Health aspects
Heterogeneity
Highly active antiretroviral therapy
HIV
HIV and co-infections
HIV infections
HIV patients
HIV/AIDS
Human immunodeficiency virus
Infection
Infections
Infectious Diseases
Internal Medicine
Lymphocytes T
Medical Microbiology
Medical research
Medicine
Medicine & Public Health
Meta-analysis
Optimization
Parasitology
Prevalence
Prevalence studies (Epidemiology)
Regression analysis
Research Article
Studies
Systematic review
T cells
Talaromyces
Talaromyces marneffei
Tropical Medicine
India
Vietnam
Asia
United States > US
China
Malaysia
Thailand
HIV/AIDS
Prevalence
Meta-analysis
Online AccessGet full text
ISSN1471-2334
1471-2334
DOI10.1186/s12879-020-05260-8

Cover

Abstract Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia. Methods In this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity. Results 159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm 3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58–16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA. Conclusions The burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered.
AbstractList Abstract Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia. Methods In this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity. Results 159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58–16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA. Conclusions The burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered.
Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia. Methods In this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity. Results 159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58–16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA. Conclusions The burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered.
Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia.BACKGROUNDTalaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia.In this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity.METHODSIn this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity.159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58-16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA.RESULTS159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58-16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA.The burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered.CONCLUSIONSThe burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered.
Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia. In this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity. 159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm.sup.3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58-16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA. The burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered.
Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia. Methods In this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity. Results 159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm 3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58–16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA. Conclusions The burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered.
Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM infection often occurs in HIV/AIDS patients even in the antiretroviral therapy (ART) era. However, there has as yet, not been a systematic analysis of the prevalence of TM infection in HIV-infected populations in Asia. Methods In this study, we searched Pubmed, Embase, Web of Science, China National Knowledge Infrastructure (CNKI), and WanFang from inception to 21 November 2018 for studies reporting TM infection in people living with HIV/AIDS (PLWHA). Our meta-analysis included studies investigating the prevalence of TM infection in PLWHA. Reviews, duplicate studies, and animal studies were excluded. A random effects model was used to estimate pooled prevalence, and meta-regression analysis was conducted to explore potential factors for heterogeneity. Results 159,064 patients with HIV infection in 33 eligible studies were included in our meta-analysis. The pooled prevalence of TM infection in PLWHA was 3.6%. Vietnam had the highest prevalence (6.4%), followed by Thailand (3.9%), China (3.3%), India (3.2%) and Malaysia (2.1%). In China, TM infection was most prevalent in South China (15.0%), while the burden in Southwest China was not very heavy (0.3%). CD4+ T-cell counts below 200 cells/mm.sup.3 contributed to the increased risk of TM infection in PLWHA (OR 12.68, 95%CI: 9.58-16.77). However, access to ART did not significantly decrease the risk of TM infection in PLWHA. Conclusions The burden of TM infection in Asia is heavy, and varies from region to region. PLWHA in lower latitude areas are more likely to suffer from TM infection. Optimization of diagnostic tools and universal screening for TM in vulnerable people to ensure early case detection and prompt antifungal treatment should be considered. Keywords: HIV/AIDS, Talaromyces marneffei, Prevalence, Meta-analysis
ArticleNumber 551
Audience Academic
Author Chen, Hui
Chen, Yaokai
Li, Yao
Liu, Xinchao
Yan, Xiaofeng
Hou, Jianhua
Li, Aixin
Qin, Yuanyuan
Huang, Xiaojie
Author_xml – sequence: 1
  givenname: Yuanyuan
  surname: Qin
  fullname: Qin, Yuanyuan
  organization: Division of Infectious Diseases, Chongqing Public Health Medical Center, Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University
– sequence: 2
  givenname: Xiaojie
  surname: Huang
  fullname: Huang, Xiaojie
  organization: Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University
– sequence: 3
  givenname: Hui
  surname: Chen
  fullname: Chen, Hui
  organization: School of Biomedical Engineering, Capital Medical University
– sequence: 4
  givenname: Xinchao
  surname: Liu
  fullname: Liu, Xinchao
  organization: Infectious Diseases Department, Peking Union Medical College Hospital
– sequence: 5
  givenname: Yao
  surname: Li
  fullname: Li, Yao
  organization: Division of Infectious Diseases, Chongqing Public Health Medical Center, Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University
– sequence: 6
  givenname: Jianhua
  surname: Hou
  fullname: Hou, Jianhua
  organization: Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University
– sequence: 7
  givenname: Aixin
  surname: Li
  fullname: Li, Aixin
  organization: Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University
– sequence: 8
  givenname: Xiaofeng
  surname: Yan
  fullname: Yan, Xiaofeng
  email: 2429918342@qq.com
  organization: Chongqing Public Health Medical Center
– sequence: 9
  givenname: Yaokai
  surname: Chen
  fullname: Chen, Yaokai
  email: yaokaichen@hotmail.com
  organization: Division of Infectious Diseases, Chongqing Public Health Medical Center
BookMark eNqNkstq3DAUhk1JaS7tC3Ql6KZdONHFN3VRmKaXDAQCSZqtOJaOJwq2NZHsSecF-tyVMynNhBKKFxLnfP8v6fjfT3Z612OSvGX0kLGqOAqMV6VMKacpzXlB0-pFsseykqVciGzn0X432Q_hhlJWVly-SnYFL3kpKrGX_Po8eoM9cQ25hBa869YaA-nA99g0aIntG9SDdX3ckSW6ZYuktSvbL8idHa7JyfzqaDb_cjG1Z8ECMaOfmrPzS4IePhIgYR0G7GCwmnhcWbwj0BvS4QAp9NCugw2vk5cNtAHfPKwHyY9vXy-PT9LTs-_z49lpqoucDykzhckrzaQw1NS84XkNjAtZZAAGSqpRylpmDQdW1E1R55kQLM_KotB5kelaHCTzja9xcKOW3saHrpUDq-4Lzi8U-HjRFhUYU_CMGxR5leW6lEgNSC5lrFWs4dHr08ZrOdYdGo394KHdMt3u9PZaLdxKlULyKqPR4P2DgXe3I4ZBdTZobFvo0Y1BxdMlzbOKlRF99wS9caOPw5sokbOCZfkjagHxAfHPuXiunkzVrBBMMlFWLFKH_6DiZ7CzOkassbG-JfiwJYjMgD-HBYwhqPnF-f-zZ1fbbLVhtXcheGyUtgNMWYsXsq1iVE05V5ucq5hzdZ9zVUUpfyL9M_ZnRWIjCsspouj_DvEZ1W9AMA0_
CitedBy_id crossref_primary_10_1016_j_micpath_2023_105985
crossref_primary_10_1093_femsre_fuae022
crossref_primary_10_1371_journal_pntd_0010388
crossref_primary_10_1021_acsomega_4c00571
crossref_primary_10_1097_CM9_0000000000002506
crossref_primary_10_3390_jof9060647
crossref_primary_10_3389_fmicb_2024_1421660
crossref_primary_10_1371_journal_pntd_0012145
crossref_primary_10_1016_j_jinf_2021_12_032
crossref_primary_10_1186_s12879_021_06232_2
crossref_primary_10_3389_fimmu_2022_980242
crossref_primary_10_1007_s12281_022_00435_z
crossref_primary_10_1093_mmy_myad111
crossref_primary_10_1007_s10096_024_04856_1
crossref_primary_10_1128_cmr_00051_22
crossref_primary_10_3389_fcimb_2022_962441
crossref_primary_10_1007_s00284_024_03623_x
crossref_primary_10_1093_genetics_iyad100
crossref_primary_10_3389_fcimb_2023_1118979
crossref_primary_10_1016_j_heliyon_2024_e32560
crossref_primary_10_1016_j_heliyon_2024_e34024
crossref_primary_10_3389_fimmu_2022_1015775
crossref_primary_10_1016_j_rinp_2021_104312
crossref_primary_10_3389_fmed_2023_1243599
crossref_primary_10_1186_s12879_024_10336_w
crossref_primary_10_1016_j_mjafi_2022_12_008
crossref_primary_10_1016_j_ijmm_2024_151615
crossref_primary_10_1111_myc_13559
crossref_primary_10_1007_s40121_023_00883_1
crossref_primary_10_2147_IDR_S379100
crossref_primary_10_1177_03000605211016761
crossref_primary_10_1007_s40121_022_00658_0
crossref_primary_10_3389_fcimb_2024_1347677
crossref_primary_10_1093_mmy_myae077
crossref_primary_10_1002_jmv_29466
crossref_primary_10_1016_S2352_3018_23_00174_1
crossref_primary_10_1093_ofid_ofac603
crossref_primary_10_1186_s12879_023_08394_7
crossref_primary_10_3389_fmed_2022_930678
crossref_primary_10_1007_s11046_022_00618_9
crossref_primary_10_1016_S1473_3099_23_00692_8
crossref_primary_10_1016_j_ijid_2024_107359
crossref_primary_10_2147_IDR_S481856
crossref_primary_10_1016_S2214_109X_21_00350_8
Cites_doi 10.1046/j.1365-4362.1999.00644.x
10.1097/00126334-199908010-00011
10.1016/S1473-3099(17)30303-1
10.1258/0956462042395159
10.1111/myc.12530
10.1093/mmy/myv068
10.1093/clinids/10.3.640
10.1111/j.1708-8305.2006.00039.x
10.1016/j.cmi.2018.04.018
10.1007/s10389-016-0750-7
10.1093/cid/cir028
10.1016/j.jinf.2007.07.002
10.1155/2016/2373424
10.1111/j.1469-0691.2006.01367.x
10.1053/jinf.2002.1062
10.1128/JCM.42.11.5070-5075.2004
10.1128/CMR.19.1.95-110.2006
10.1016/j.medmal.2014.09.008
10.1371/journal.pone.0130376
10.1086/338154
10.1186/s12879-016-1809-3
10.1136/sextrans-2013-051184.0290
10.1371/journal.pone.0075915
10.7326/0003-4819-155-8-201110180-00009
10.1620/tjem.244.231
10.1007/s11046-012-9577-0
10.1086/319348
10.1111/j.1468-1293.2008.00674.x
10.1111/j.1468-1331.2004.00879.x
10.1007/s10096-016-2724-7
10.1186/s13071-017-2558-x
10.1046/j.1525-1470.1999.00093.x
10.1016/S2352-3018(17)30005-X
10.1002/art.38219
10.1016/j.trstmh.2004.01.011
10.1111/j.1468-3083.2011.04429.x
10.1016/j.ijpara.2004.08.009
10.1128/JCM.37.8.2699-2702.1999
10.1093/cid/cit058
10.1371/journal.pone.0195569
10.1097/QAI.0000000000001216
10.1016/S0140-6736(94)91287-4
10.1016/j.micpath.2017.01.026
10.1093/clinids/23.1.125
10.2340/00015555-1107
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
IOV
ISR
3V.
7QL
7T2
7U9
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12879-020-05260-8
DatabaseName Springer Nature OA Free Journals
CrossRef
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Public Health Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2334
EndPage 14
ExternalDocumentID oai_doaj_org_article_add6242de35845c79e0da929942d81f2
PMC7392840
A631913781
10_1186_s12879_020_05260_8
GeographicLocations India
Vietnam
Asia
United States--US
China
Malaysia
Thailand
GeographicLocations_xml – name: India
– name: Asia
– name: Vietnam
– name: China
– name: Thailand
– name: Malaysia
– name: United States--US
GrantInformation_xml – fundername: Major Project of Beijing Municipal Science and Technology Committee
  grantid: D161100000416003, D171100000517003
– fundername: the National Science and Technology Major Project of China during the 13th Five-year plan period
  grantid: 2018ZX10302104,2017ZX10201101
– fundername: Chongqing Municipal Science and Technology Bureau TCM Key Research Project
  grantid: ZY201801003
– fundername: Beijing Key Laboratory
  grantid: BZ0089
– fundername: 2018 Beijing Youan Hospital Scientific Research Project for Young & Middle-aged Talent’s Cultivation
  grantid: YNKTTS20180107
– fundername: the National Natural Science Foundation of China
  grantid: No. 81701984
– fundername: ;
  grantid: BZ0089
– fundername: ;
  grantid: YNKTTS20180107
– fundername: ;
  grantid: D161100000416003, D171100000517003
– fundername: ;
  grantid: No. 81701984
– fundername: ;
  grantid: ZY201801003
– fundername: ;
  grantid: 2018ZX10302104,2017ZX10201101
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IOV
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
PMFND
3V.
7QL
7T2
7U9
7XB
8FK
AZQEC
C1K
DWQXO
H94
K9.
M7N
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c652t-1d6d58c193d0db2f25ba123964aada70ce99b94f2a16bf6b5433154766c564cb3
IEDL.DBID BENPR
ISSN 1471-2334
IngestDate Wed Aug 27 01:28:00 EDT 2025
Thu Aug 21 18:36:25 EDT 2025
Fri Sep 05 01:04:43 EDT 2025
Fri Jul 25 21:42:27 EDT 2025
Tue Jun 17 20:56:34 EDT 2025
Tue Jun 10 20:44:42 EDT 2025
Fri Jun 27 03:35:14 EDT 2025
Fri Jun 27 04:59:43 EDT 2025
Tue Jul 01 01:57:43 EDT 2025
Thu Apr 24 23:09:11 EDT 2025
Sat Sep 06 07:26:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HIV/AIDS
Prevalence
Meta-analysis
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c652t-1d6d58c193d0db2f25ba123964aada70ce99b94f2a16bf6b5433154766c564cb3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.proquest.com/docview/2435161457?pq-origsite=%requestingapplication%&accountid=15518
PMID 32727383
PQID 2435161457
PQPubID 42582
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_add6242de35845c79e0da929942d81f2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7392840
proquest_miscellaneous_2429054817
proquest_journals_2435161457
gale_infotracmisc_A631913781
gale_infotracacademiconefile_A631913781
gale_incontextgauss_ISR_A631913781
gale_incontextgauss_IOV_A631913781
crossref_citationtrail_10_1186_s12879_020_05260_8
crossref_primary_10_1186_s12879_020_05260_8
springer_journals_10_1186_s12879_020_05260_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-07-29
PublicationDateYYYYMMDD 2020-07-29
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-29
  day: 29
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle BMC infectious diseases
PublicationTitleAbbrev BMC Infect Dis
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References 5260_CR56
PN Singh (5260_CR4) 1999; 37
5260_CR14
W Jing (5260_CR44) 1999; 38
PF Whiting (5260_CR18) 2011; 155
ZD Wang (5260_CR15) 2017; 4
GL Tang (5260_CR37) 2009; 9
YH Li (5260_CR21) 2018; 40
PL Bulterys (5260_CR51) 2013; 56
5260_CR8
5260_CR10
XJ Huang (5260_CR33) 2011; 91
ZF Zhai (5260_CR26) 2016; 24
KH Ranjana (5260_CR13) 2002; 45
S Antinori (5260_CR57) 2006; 13
SA Kolalapudi (5260_CR28) 2014; 70
N Vanittanakom (5260_CR7) 2006; 19
A Horman (5260_CR16) 2004; 34
5260_CR49
N Xie (5260_CR32) 2012; 23
W Manosuthi (5260_CR38) 2007; 55
JK Louie (5260_CR12) 2004; 15
S Chariyalertsak (5260_CR55) 2002; 34
J Han (5260_CR30) 2013; 27
V Sobanski (5260_CR19) 2014; 66
L Thuy (5260_CR2) 2011; 52
CY Lin (5260_CR35) 2009; 10
S Tansuphasawadikul (5260_CR45) 1999; 21
Y Hu (5260_CR53) 2013; 175
HY Sun (5260_CR11) 2006; 12
S Lu (5260_CR47) 2016; 54
H Gugnani (5260_CR3) 2004; 42
LF Huang (5260_CR34) 2010; 49
TA Duong (5260_CR6) 1996; 23
S Chariyalertsak (5260_CR42) 2001; 32
K Supparatpinyo (5260_CR1) 1994; 344
TX Changhong Zeng (5260_CR52) 2009; 35
W Pang (5260_CR20) 2018; 244
W Ni (5260_CR22) 2018; 15
CH Zeng (5260_CR36) 2009; 35
ZD Wang (5260_CR50) 2018; 11
Y Li (5260_CR54) 2017; 105
Z Deng (5260_CR5) 1988; 10
HTA Hien (5260_CR48) 2016; 59
5260_CR24
ZR Tang (5260_CR39) 2007; 01
K Subsai (5260_CR41) 2004; 11
VT Son (5260_CR9) 2014; 44
YF Yen (5260_CR23) 2017; 74
5260_CR27
AH Limper (5260_CR46) 2017; 17
S Wasserman (5260_CR17) 2016; 16
5260_CR29
GS Su (5260_CR31) 2012; 34
S Wananukul (5260_CR43) 1999; 16
W Chierakul (5260_CR40) 2004; 98
T Qi (5260_CR25) 2016; 35
References_xml – volume: 38
  start-page: 457
  issue: 6
  year: 1999
  ident: 5260_CR44
  publication-title: Int J Dermatol
  doi: 10.1046/j.1365-4362.1999.00644.x
– volume: 21
  start-page: 326
  issue: 4
  year: 1999
  ident: 5260_CR45
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/00126334-199908010-00011
– volume: 17
  start-page: e334
  issue: 11
  year: 2017
  ident: 5260_CR46
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(17)30303-1
– volume: 15
  start-page: 758
  issue: 11
  year: 2004
  ident: 5260_CR12
  publication-title: Int J STD AIDS
  doi: 10.1258/0956462042395159
– volume: 59
  start-page: 773
  issue: 12
  year: 2016
  ident: 5260_CR48
  publication-title: Mycoses
  doi: 10.1111/myc.12530
– volume: 40
  start-page: 168
  issue: 2
  year: 2018
  ident: 5260_CR21
  publication-title: J Dermatol Venereol
– volume: 54
  start-page: 162
  issue: 2
  year: 2016
  ident: 5260_CR47
  publication-title: Med Mycol
  doi: 10.1093/mmy/myv068
– volume: 34
  start-page: 1000
  issue: 8
  year: 2012
  ident: 5260_CR31
  publication-title: Guangxi Med J
– volume: 10
  start-page: 640
  issue: 3
  year: 1988
  ident: 5260_CR5
  publication-title: Rev Infect Dis
  doi: 10.1093/clinids/10.3.640
– volume: 13
  start-page: 181
  issue: 3
  year: 2006
  ident: 5260_CR57
  publication-title: J Travel Med
  doi: 10.1111/j.1708-8305.2006.00039.x
– ident: 5260_CR8
  doi: 10.1016/j.cmi.2018.04.018
– volume: 24
  start-page: 505
  issue: 6
  year: 2016
  ident: 5260_CR26
  publication-title: J Public Health Heidelberg
  doi: 10.1007/s10389-016-0750-7
– volume: 01
  start-page: 28
  year: 2007
  ident: 5260_CR39
  publication-title: Applied Prev Med
– volume: 9
  start-page: 1652
  issue: 7
  year: 2009
  ident: 5260_CR37
  publication-title: Ch in J Misdiagn
– volume: 52
  start-page: 945
  issue: 7
  year: 2011
  ident: 5260_CR2
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir028
– volume: 55
  start-page: 464
  issue: 5
  year: 2007
  ident: 5260_CR38
  publication-title: J Infect
  doi: 10.1016/j.jinf.2007.07.002
– ident: 5260_CR24
  doi: 10.1155/2016/2373424
– volume: 12
  start-page: 381
  issue: 4
  year: 2006
  ident: 5260_CR11
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2006.01367.x
– volume: 45
  start-page: 268
  issue: 4
  year: 2002
  ident: 5260_CR13
  publication-title: J Infect
  doi: 10.1053/jinf.2002.1062
– volume: 42
  start-page: 5070
  issue: 11
  year: 2004
  ident: 5260_CR3
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.42.11.5070-5075.2004
– volume: 19
  start-page: 95
  issue: 1
  year: 2006
  ident: 5260_CR7
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.19.1.95-110.2006
– volume: 44
  start-page: 495
  issue: 11–12
  year: 2014
  ident: 5260_CR9
  publication-title: Medecine Et Maladies Infectieuses
  doi: 10.1016/j.medmal.2014.09.008
– ident: 5260_CR27
  doi: 10.1371/journal.pone.0130376
– volume: 35
  start-page: 46
  issue: 2
  year: 2009
  ident: 5260_CR36
  publication-title: South China J Prev Med
– volume: 23
  start-page: 89
  issue: 9
  year: 2012
  ident: 5260_CR32
  publication-title: Hainan Med J
– volume: 34
  start-page: 277
  issue: 2
  year: 2002
  ident: 5260_CR55
  publication-title: Clin Infect Dis
  doi: 10.1086/338154
– volume: 16
  start-page: 482
  year: 2016
  ident: 5260_CR17
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-016-1809-3
– volume: 70
  start-page: AB108
  issue: 5
  year: 2014
  ident: 5260_CR28
  publication-title: J Am Acad Dermatol
– ident: 5260_CR29
  doi: 10.1136/sextrans-2013-051184.0290
– ident: 5260_CR10
  doi: 10.1371/journal.pone.0075915
– volume: 155
  start-page: 529
  issue: 8
  year: 2011
  ident: 5260_CR18
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-155-8-201110180-00009
– volume: 244
  start-page: 231
  issue: 3
  year: 2018
  ident: 5260_CR20
  publication-title: Tohoku J Exp Med
  doi: 10.1620/tjem.244.231
– volume: 175
  start-page: 57
  issue: 1–2
  year: 2013
  ident: 5260_CR53
  publication-title: Mycopathologia
  doi: 10.1007/s11046-012-9577-0
– volume: 15
  start-page: 139
  issue: 19
  year: 2018
  ident: 5260_CR22
  publication-title: China Medical Herald
– volume: 32
  start-page: 955
  issue: 6
  year: 2001
  ident: 5260_CR42
  publication-title: Clin Infect Dis
  doi: 10.1086/319348
– volume: 10
  start-page: 191
  issue: 3
  year: 2009
  ident: 5260_CR35
  publication-title: Hiv Medicine
  doi: 10.1111/j.1468-1293.2008.00674.x
– volume: 11
  start-page: 755
  issue: 11
  year: 2004
  ident: 5260_CR41
  publication-title: Eur J Neurol
  doi: 10.1111/j.1468-1331.2004.00879.x
– volume: 35
  start-page: 1767
  issue: 11
  year: 2016
  ident: 5260_CR25
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-016-2724-7
– volume: 35
  start-page: 46
  issue: 2
  year: 2009
  ident: 5260_CR52
  publication-title: South China J Prev Med
– volume: 11
  start-page: 28
  issue: 1
  year: 2018
  ident: 5260_CR50
  publication-title: Parasit Vectors
  doi: 10.1186/s13071-017-2558-x
– volume: 16
  start-page: 359
  issue: 5
  year: 1999
  ident: 5260_CR43
  publication-title: Pediatr Dermatol
  doi: 10.1046/j.1525-1470.1999.00093.x
– volume: 4
  start-page: e177
  issue: 4
  year: 2017
  ident: 5260_CR15
  publication-title: Lancet HIV
  doi: 10.1016/S2352-3018(17)30005-X
– volume: 66
  start-page: 407
  issue: 2
  year: 2014
  ident: 5260_CR19
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.38219
– volume: 98
  start-page: 678
  issue: 11
  year: 2004
  ident: 5260_CR40
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1016/j.trstmh.2004.01.011
– volume: 27
  start-page: 376
  issue: 3
  year: 2013
  ident: 5260_CR30
  publication-title: J Eur Acad Dermatol Venereol
  doi: 10.1111/j.1468-3083.2011.04429.x
– volume: 49
  start-page: 653
  issue: 8
  year: 2010
  ident: 5260_CR34
  publication-title: Chin J Intern Med
– ident: 5260_CR49
– volume: 34
  start-page: 1337
  issue: 12
  year: 2004
  ident: 5260_CR16
  publication-title: Int J Parasitol
  doi: 10.1016/j.ijpara.2004.08.009
– volume: 37
  start-page: 2699
  issue: 8
  year: 1999
  ident: 5260_CR4
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.37.8.2699-2702.1999
– volume: 56
  start-page: 1273
  issue: 9
  year: 2013
  ident: 5260_CR51
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit058
– ident: 5260_CR14
  doi: 10.1371/journal.pone.0195569
– ident: 5260_CR56
– volume: 74
  start-page: 117
  issue: 2
  year: 2017
  ident: 5260_CR23
  publication-title: Jaids J Acquired Immune Deficiency Syndromes
  doi: 10.1097/QAI.0000000000001216
– volume: 344
  start-page: 110
  issue: 8915
  year: 1994
  ident: 5260_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)91287-4
– volume: 105
  start-page: 321
  year: 2017
  ident: 5260_CR54
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2017.01.026
– volume: 23
  start-page: 125
  issue: 1
  year: 1996
  ident: 5260_CR6
  publication-title: Clin Infect Dis
  doi: 10.1093/clinids/23.1.125
– volume: 91
  start-page: 552
  issue: 5
  year: 2011
  ident: 5260_CR33
  publication-title: Acta Derm Venereol
  doi: 10.2340/00015555-1107
SSID ssj0017829
Score 2.4898171
SecondaryResourceType review_article
Snippet Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening...
Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening infection. TM...
Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated life-threatening...
Abstract Background Talaromyces marneffei (TM) is a dimorphic fungus mainly prevalent in Southeast Asian countries, which often causes disseminated...
SourceID doaj
pubmedcentral
proquest
gale
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Acquired immune deficiency syndrome
AIDS
Analysis
Antifungal agents
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Asymmetry
Bias
Cancer
Care and treatment
CD4 antigen
Diagnostic software
Diagnostic systems
Fungi
Fungicides
Health aspects
Heterogeneity
Highly active antiretroviral therapy
HIV
HIV and co-infections
HIV infections
HIV patients
HIV/AIDS
Human immunodeficiency virus
Infection
Infections
Infectious Diseases
Internal Medicine
Lymphocytes T
Medical Microbiology
Medical research
Medicine
Medicine & Public Health
Meta-analysis
Optimization
Parasitology
Prevalence
Prevalence studies (Epidemiology)
Regression analysis
Research Article
Studies
Systematic review
T cells
Talaromyces
Talaromyces marneffei
Tropical Medicine
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JjtQwELXQHBAXxCoCAzIIiQNEE6fjjVuzjLqRAIlZNDernNjQ0nSCejnwA3w3VVl6CKOBC7coVdlc5VriqmfGnguts2i9TxXQMmOlZOqFyVKjVBAaKKJvC2Q_qdlJ8eFMnv221RfVhHXwwN3AUVkNtTBUYYKuUpbahqwC9OkWzxkRW-ub2WxIpvr1A_R7dmiRMepgjVZY25RSJcI3wVcZuaEWrf-yTb5cJ_nHYmnrgw5vsZt98Min3UvfZtdCfYdd_9gvj99lP7umBN5EfgyYsjbLH2gG-BJWNdVtLPhQelXjEe-Kx_n5gv4pcPohy2fz04Pp_N0RkafrBfCui5Fj1MvDCl5z4BfQz7xre-FQV3wZNpBCD3Byj50cvj9-O0v7jRbSUsl8k4pKVdKUGMtVWeXzmEsP6NGsKgAq0FkZrPW2iDkI5aPyktqsZKGVKqUqSj-5z_bqpg4PGLd5jCZglgRqQhQINkQoZMTbeSQkTAzj7soehZw2wzh3bTZilOtk5VBWrpWVMwl7ubvme4fB8VfuNyTOHSfhZ7cnUKtcr1XuX1qVsGekDI4QMmoqwfkK2_XazT-fuqlCqyUm2oirmI6-jJhe9EyxwQ8toW97wOEi5K0R5_6IE-d5OSYPiul6O7N2OUa7GLMXUifs6Y5MV1LtXB2aLfHkFgNzI5BHjxR6NEZjSr341mKNa4yfTZEl7NWg-hcPv1oGD_-HDB6xG3k7Y3Wa2322t1ltw2OMADf-STvZfwFVXVSj
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA7rCuKLeMXqKlEEH7Ru22lugsh4WWYEFdydZd9C0ibrwEyrcwH3D_i7PSdtZ6h7eRt6TqZtziVfei4h5EUqROKVtTE3GGYsOYttKpNYcu5SYRDRhwTZb3w0yb-csJMd0h131E7g8sKtHZ4nNVnM3vz5ffYeDP5dMHjJ95fgY4WKcSOE3UvgRtfI9RAvwlS-fBtVgNVQdYUzF47rLU6hh_95T30-e_K_EGpYmQ5uk1stpKTDRgfukB1X3SU3vrZB83vkb1OqQGtPjwy8bT0_A-dA52ZRYTbHlHYJWRX8ok1KOZ1N8UsDxc-0dDQ-3h-OPx0iebicGtrUNlLAwtQtzFtq6LYhNG2KYaipSjp3KxObtu3JfTI5-Hz0cRS3xy_EBWfZKk5LXjJZAMIrk9JmPmPWwDqneG5MaURSOKWsyn1mUm49twyLr1guOC8Yzws7eEB2q7pyDwlVmffSwd7J8AFSjFPOm5x5-DsLhIik3bzrou1NjkdkzHTYo0iuG1lpkJUOstIyIq82Y341nTmu5P6A4txwYlftcKFenOrWSDX4eiyXKd0AYBkrhHJJaQA_KrgmU59F5Dkqg8a-GRUm5pya9XKpx9-P9ZCDL0sHQqaXMR3-6DG9bJl8DS9amLYYAqYL-3H1OPd6nGD9RZ_cKabujEdngIEByedMROTZhowjMaOucvUaeTIFcF2mwCN6Ct2boz6lmv4MHcgFoGqZJxF53an-9uaXy-DR1c_6mNzMgi1iWtQe2V0t1u4JIL6VfRrM-B9Tc09t
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELZgkRAXxFOEXZBBSBwg2jqN7ZhbKaxaJEBiH9qbNU7spdI2QU172D_A72Ymjy5hWSRuVWacKp7x-Jt45gtjr4TWo2CcixXQMWOhZOxENoozpbzQQIi-KZD9ombH6adTedrR5FAvzO_n9yJT-zXGT21iSnKImQRvcpPdkhh4yZunaro9McCdzvRNMX8dN9h4Gn7-q1H4amXkH8ejza5zcI_d7eAin7T2vc9u-PIBu_25OxB_yH62bQi8CvwIMEmtlhe48PkSViVVaix4X2xV4i_elovz8wW9ReD0CpbP5if7k_mHQxJP6gXwtm-RI87lfgXvOPBLsmfeNrpwKAu-9GuIoaM0ecSODz4eTWdx92mFOFcyWceiUIXMckRvxahwSUikA9zDjEoBCtCj3BvjTBoSEMoF5SQ1VslUK5VLleZu_JjtlFXpnzBukhAyj3kRqDFJwBsfIJUBb-dQEDHRz7vNO95x-vzFuW3yj0zZ1lYWbWUbW9ksYm-2Y360rBv_1H5P5txqEmN2cwEdyXYL0GIcp1aYwo8RcslcGz8qALGhwWuZCEnEXpIzWOLEKKno5gw2dW3nX0_sRGGcEmOdieuUDr8NlF53SqHCB82ha3TA6SKurYHm3kATV3Y-FPeOabvIUtsE8S2i9FTqiL3YimkkVcuVvtqQTmIQimcCdfTAoQdzNJSUi-8Nu7hGxIxZf8Te9q5_-efX2-Dp_6nvsjtJszZ1nJg9trNebfwzRHdr97xZ1r8A4DlFNA
  priority: 102
  providerName: Springer Nature
Title Burden of Talaromyces marneffei infection in people living with HIV/AIDS in Asia during ART era: a systematic review and meta-analysis
URI https://link.springer.com/article/10.1186/s12879-020-05260-8
https://www.proquest.com/docview/2435161457
https://www.proquest.com/docview/2429054817
https://pubmed.ncbi.nlm.nih.gov/PMC7392840
https://doaj.org/article/add6242de35845c79e0da929942d81f2
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Za9tAEF4SB0pfSk_qNDXbUuhDK6yVtVehFNtNsAtxi3Ng-rKspFVqiKXUx0P_QH93Z3TYqCF5WWzNSJb3mJndmfmGkHdMSj_VUeQJi27GRHAvYsr3lBCOSYsWfREgOxGji_DbjM_2yKTOhcGwylomFoI6yWM8I-8GoNfBOgm5_HLz28OqUehdrUto2Kq0QvK5gBjbJwcgkrnfIgeD48mP6davAPpQ16kzSnRXIJ2l9nALhbgn8IoN9VSg-N-W1bfjJ_9zoha66eQxeVQZlbRfzoInZM9lT8mD08pt_oz8LZMVaJ7Scwtb2XzxB8QDXdhlhvEcc1qHZGXwiZZB5fR6jmcNFA9q6Wh82e2Pv54hub-aW1pmN1Kwhqlb2k_U0h0kNC3TYajNErpwa-vZCvjkObk4OT4fjryqAIMXCx6sPZaIhKsYbLzET6IgDXhkQdNpEVqbWOnHTutIh2lgmYhSEXFMv-KhFCLmIoyj3gvSyvLMvSRUB2mqHOyerOghxTrtUhvyFB4XAaFNWN3vJq7QybFIxrUpdilKmHKsDIyVKcbKqDb5sL3npsTmuJd7gMO55URc7eJCvrwy1TI1IO0xYSZxPTDMeCy18xMLFqSGa4qlQZu8xclgEDkjw9CcK7tZrcz4-6XpC5BmrCcVu4vpbNpgel8xpTn80dhW6RDQXYjI1eA8anDC-o-b5Hpimkr-rMxutbTJmy0Z78SYuszlG-QJNBjsigGPbEzoRh81Kdn8V4FBLsGuVqHfJh_rqb_78bvH4PD-d31FHgbFWpReoI9Ia73cuNdg862jDtmXMwmtGrJOtajh21AMO8UpCrSnoYJ2Ovj5DzEOWEc
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BqdBLwgPkXZAINAPEDUxE3sGGlCHdvUsq2grZv2ZpzE2SqtyWhaof0Bfha_jbvEaRWm7W1vUe6StL7zffi-CHnnCeGmMoocrjHMmPDAibzQdULOjSc0WvRlguyQ94_8byfByQr5W9fCYFplLRNLQZ3kMZ6RdxjodbBO_EB8ufjl4NQojK7WIzS0Ha2QbJQtxmxhx665_A0uXLEx2AJ6v2dsZ3v0te_YKQNOzAM2c7yEJ0EYgyGTuEnEUhZEGsS55L7WiRZubKSMpJ8y7fEo5VGANUaBLziPA-7HURfee4es-niA0iKrm9vDHweLOAboX1mX6oS8U4A2ENJBlw37rMCSNNRhOTXgqm64mq_5X9C21IU7D8kDa8TSXsV1j8iKyR6Tu_s2TP-E_KmKI2ie0pEG1zmfXII4ohM9zTB_ZEzrFLAMrmiVxE7Px3i2QfFgmPYHx53eYOsQwb1irGlVTUnB-qZmqj9TTZctqGlVfkN1ltCJmWlH20YrT8nRrZDiGWlleWaeEypZmoYGvDXNuwjRRppU-0EKr4sA0CZeve4qtt3QcSjHuSq9opCrilYKaKVKWqmwTT4unrmoeoHciL2J5FxgYh_v8kY-PVVWLCjQLligk5guGIJBLKRxEw0Wq4R7oZeyNnmLzKCwU0eGqUCnel4UavD9WPU4SE-vK0LvOqTDgwbSB4uU5vBHY23LL2C5sANYA3O9gQnyJm6Ca8ZUVt4Vark72-TNAoxPYg5fZvI54jAJDkLoAY5oMHRjjZqQbHxW9jwXYMeHvtsmn2rWX378ehq8uPm3vib3-qP9PbU3GO6ukfus3JfCYXKdtGbTuXkJ9uYsemU3NSU_b1uO_APx3o91
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEF5BK1VcUHmJtAUWhMQBrNiO98XNUKIkQEGkrXpb7dq7JVJjV3kc-AP8bmb8SDGlSNwiz6wj7-zOfuOZ-UzIy0iI0CtrA24wzZhzFthIhoHk3EXCIKKvCmSP-OgkmZyxs9-6-Ktq9zYlWfc0IEtTsepf5r7e4pL3l-BVhQow9EG-Erj1bbItmVIQfm2n6WQ62WQS4ARUbbPMX0d2DqSKt_-6d75eMflH2rQ6jYa75G4DI2la2_0eueWK-2Tnc5Mof0B-1u0JtPT02EDwWs5_gEOgc7MosIJjRtsirAJ-0bqMnF7M8O0CxVezdDQ-7afjwymK0-XM0LqfkQL-pW5h3lJDr0igad0AQ02R07lbmcA0VCcPycnww_H7UdB8ciHIOItXQZTznMkMUF0e5jb2MbMGzjbFE2NyI8LMKWVV4mMTceu5ZdhwxRLBecZ4ktnBI7JVlIV7TKiKvZcO4iXDBygxTjlvEubhdhYEPRK1866zho8cP4txoau4RHJd20qDrXRlKy175PVmzGXNxvFP7Xdozo0mMmlXF8rFuW42pgb_ji0yuRsAFGOZUC7MDWBGBddk5OMeeYGLQSNXRoHFOOdmvVzq8ZdTnXLwX9FAyOgmpem3jtKrRsmX8KCZaRogYLqQg6ujedDRhB2fdcXtwtSNx1nqGHAvoPeEiR55vhHjSKyiK1y5Rp1YAUSXEeiIzoLuzFFXUsy-V6zjApC0TMIeedMu_as_v9kGe_-n_ozsfD0c6k_jo4_75E5cbVMRxOqAbK0Wa_cEAODKPm32-C_MUVHh
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Burden+of+Talaromyces+marneffei+infection+in+people+living+with+HIV%2FAIDS+in+Asia+during+ART+era%3A+a+systematic+review+and+meta-analysis&rft.jtitle=BMC+infectious+diseases&rft.au=Qin%2C+Yuanyuan&rft.au=Huang%2C+Xiaojie&rft.au=Chen%2C+Hui&rft.au=Liu%2C+Xinchao&rft.date=2020-07-29&rft.pub=BioMed+Central&rft.eissn=1471-2334&rft.volume=20&rft.spage=1&rft_id=info:doi/10.1186%2Fs12879-020-05260-8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon